Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Florida - based Vaccine and Gene Therapy Institute (VGTI) and Merck have entered into research collaboration agreement to advance therapies for HIV cure.
Subscribe to our email newsletter
In order to eradicate and predict HIV, investigators of both companies decided to develop methods to characterize potential latency candidates and discover and validate targets and pathways to eliminate infected cells and to identify biomarkers.
VGTI-FL co-director and CSO and researcher Rafick-Pierre Sekaly said the collaboration with Merck will not only allow them to enhance their discovery efforts but also to enhance their efforts to develop drugs that may help the global effort to eradicate HIV.